4QZ-15222-85464
2 vaccinations
3 coded responses
31 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 750 / TX
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
-
2021-04-12
Survey response — day 35, single doseMedDRA: Abdominal pain upper, Cough, Fatigue, Mucosal discolouration, Muscular weakness, Nasal congestion, Oropharyngeal pain, Productive cough, Wheezing — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Wheezing, cough, high volume of phlegm, dark yellow/brown/black mucus, stomach ache, muscle weakness, stuffy nose, sore throat, and general tiredness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Survey response — day 42, single doseMedDRA: Cough, Productive cough, Wheezing — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Wheezing, heavy phlegm production, and consistent cough. Felling a little better than last week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-07
- 2021-09-06
-
2022-01-13
Dose 2 — Pfizer-BioNTech
- 2022-01-13
-
2022-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-01-16
- 2022-01-17
- 2022-01-18
- 2022-01-19
- 2022-01-20
- 2022-01-27
- 2022-02-03
- 2022-02-10
- 2022-02-17
- 2022-02-24
- 2022-04-14
-
2022-07-14
Survey response — 6 months, dose 2MedDRA: Cough, Dyspnoea, Medical counselling, Oropharyngeal pain, SARS-CoV-2 test negative, Self-medication, Wheezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: COVID-19 like symptoms with negative tests. Severe sore throat, consistent cough for 5 days, labored breathing with heavy wheezing. · Healthcare visit (other): No-one would see me in person. Email communications only recommending over the counter remedies.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-15
-
2022-07-18
Call successfulCompleted over the phone
- 2023-01-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | |
| 2 | 2022-01-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 7 — day 35, single dose
Symptoms: Wheezing, cough, high volume of phlegm, dark yellow/brown/black mucus, stomach ache, muscle weakness, stuffy nose, sore throat, and general tiredness.
Release 7 — day 42, single dose
Symptoms: Wheezing, heavy phlegm production, and consistent cough. Felling a little better than last week.
Release 12 — 6 months, dose 2
Symptoms: COVID-19 like symptoms with negative tests. Severe sore throat, consistent cough for 5 days, labored breathing with heavy wheezing.
Healthcare visit (other): No-one would see me in person. Email communications only recommending over the counter remedies.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Self-medication | · | · | ✓ |
| SD | Abdominal pain upper | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Mucosal discolouration | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Productive cough | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Wheezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release